Clinical Trial Detail

NCT ID NCT03873805
Title PSCA-CAR T Cells in Treating Patients With PSCA+ Metastatic Castration Resistant Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors City of Hope Medical Center
Indications

prostate cancer

Therapies

Cyclophosphamide + Fludarabine

Anti-PSCA(dCH2)BBz-CAR T-cells

Age Groups: adult senior

No variant requirements are available.